| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (363kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-784012
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.78401
Zusammenfassung
Clinical trials conducted during the COVID-19 pandemic demonstrated the value of adaptive design methods in emerging disease settings, when there can be considerable uncertainty around disease natural history, anticipated endpoint effect sizes and population size. In such settings, there may also be uncertainty regarding the most appropriate primary endpoint. This might lead to an ...

Nur für Besitzer und Autoren: Kontrollseite des Eintrags

Downloadstatistik